June 13, 2026 Novo Nordisk and Eli Lilly Dominance Under Threat as Drugmakers Bet Big on Obesity Treatment
April 27, 2026 Regeneron Joins Major Drugmakers in Pricing Concessions Under Trump Agreements for New and Existing Medicines
April 26, 2026 FDA Supports Psychedelic-Based Medicines for Treatment-Resistant Depression, PTSD, and Substance Use Disorders
